DCBO:NASDAQDocebo Inc. Analysis

Docebo’s stock is trading at $16.64, well below its 20‑day SMA of $19.04 and 50‑day SMA of $18.72, indicating short‑term weakness, while the RSI of 37 suggests the shares are approaching oversold territory. Fundamentally, the company posts a healthy 10.5% revenue growth rate, an impressive 80% gross margin, and a 56.9% ROE, outpacing many peers. The DCF‑derived fair value of roughly $8.20, however, points to a valuation gap, even as the forward PE of 8.6 signals relative cheapness versus the industry PE average of 32.
Recent material news highlights the completion of a substantial issuer bid and the integration of the 365Talents platform, underscoring management’s confidence and a push to broaden the AI‑driven learning suite. The balance sheet is strong, with $74.0 M cash, minimal debt, and positive operating cash flow, supporting continued investment in product development.
Given the mixed technical signals, solid growth fundamentals, and a valuation that appears both attractive on a relative basis and stretched on an absolute DCF basis, the stock warrants a nuanced stance: cautious short‑term positioning with a bias toward buying on medium‑ to long‑term horizons.